These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Activities of catecholamines on the rat muscle glycogenolytic (beta-2) receptor. Arnold A; Selberis WH Experientia; 1968 Oct; 24(10):1010-1. PubMed ID: 5711858 [No Abstract] [Full Text] [Related]
8. Interactions of sympathomimetic amines and adrenergic blocking agents at receptor sites mediating lipolysis in the rat. Kennedy BL; Ellis S Proc Soc Exp Biol Med; 1969 Apr; 130(4):1223-9. PubMed ID: 5780004 [No Abstract] [Full Text] [Related]
9. Non-shivering thermogenesis in the potoroo, Potorous tridactylus (Kerr). Nicol SC Comp Biochem Physiol C Comp Pharmacol; 1978; 59(1):33-7. PubMed ID: 24519 [No Abstract] [Full Text] [Related]
10. [Action of various analeptics on the kidney]. Lareng L Anesth Analg (Paris); 1969; 26(5):707-10. PubMed ID: 4391673 [No Abstract] [Full Text] [Related]
11. Effects of nicotine and sympathomimetic amines on potassium intoxication. Lum BK; Lockwood RH J Pharmacol Exp Ther; 1972 Apr; 181(1):147-54. PubMed ID: 4401177 [No Abstract] [Full Text] [Related]
12. Effect of catecholamines and adrenergic antagonists on blood glucose, free fatty acids and liver glycogen levels in fed rats. Bugajski J; Hano J; Zdebska A Pol J Pharmacol Pharm; 1978; 30(6):799-818. PubMed ID: 755244 [TBL] [Abstract][Full Text] [Related]
13. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines. Galitzky J; Reverte M; Carpene C; Lafontan M; Berlan M J Pharmacol Exp Ther; 1993 Jul; 266(1):358-66. PubMed ID: 8101220 [TBL] [Abstract][Full Text] [Related]
14. Role of beta-adrenergic receptors in counterregulation to insulin-induced hypoglycemia. Abramson EA; Arky RA Diabetes; 1968 Mar; 17(3):141-6. PubMed ID: 5638576 [No Abstract] [Full Text] [Related]
15. Influence of catecholamines on some of the important carbohydrate and lipid intermediary metabolites during their pressor responses. Chopde CT; Brahmankar DM; Dorle AK Biochem Pharmacol; 1973 Mar; 22(5):575-80. PubMed ID: 4692168 [No Abstract] [Full Text] [Related]
16. Cardiostimulatory effects of oxyfedrine, DMPP and sympathomimetics in relation to their 3H-noradrenaline-releasing properties. Kukovetz WR; Pöch G Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(1):59-70. PubMed ID: 4395352 [No Abstract] [Full Text] [Related]
17. In vitro study of esterases sensitivity to catecholamines in starved and fed rats. Giri SN; Freedland RA; Peoples SA Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):276-83. PubMed ID: 5367303 [No Abstract] [Full Text] [Related]
18. Adrenergic changes due to pertussis: insulin, glucose and free fatty acids. Tabachnick II; Gulbenkian A Eur J Pharmacol; 1969 Aug; 7(2):186-95. PubMed ID: 4390565 [No Abstract] [Full Text] [Related]
19. Studies on a biphasic lipolytic response to catecholamines in isolated fat cells. Allen DO; Hillman CC; Ashmore J Biochem Pharmacol; 1969 Sep; 18(9):2233-40. PubMed ID: 4390559 [No Abstract] [Full Text] [Related]